<Suppliers Price>

4-(bromomethyl)phenyl acetic acid

Names

[ CAS No. ]:
13737-36-5

[ Name ]:
4-(bromomethyl)phenyl acetic acid

[Synonym ]:
4-(Carboxymethyl)benzyl Bromide
2-[4-(bromomethyl)phenyl]acetic acid
MFCD00010632
4-(BROMOMETHYL)PHENYLACETIC ACID
Benzeneacetic acid, 4-(bromomethyl)-
[4-(Bromomethyl)phenyl]acetic acid
4-(bromomethyl)phenyl acetic acid

Chemical & Physical Properties

[ Density]:
1.6±0.1 g/cm3

[ Boiling Point ]:
343.1±22.0 °C at 760 mmHg

[ Melting Point ]:
179-183 °C(lit.)

[ Molecular Formula ]:
C9H9BrO2

[ Molecular Weight ]:
229.071

[ Flash Point ]:
161.3±22.3 °C

[ Exact Mass ]:
227.978592

[ PSA ]:
37.30000

[ LogP ]:
2.21

[ Vapour Pressure ]:
0.0±0.8 mmHg at 25°C

[ Index of Refraction ]:
1.599

[ Storage condition ]:
Store at RT.

MSDS

Safety Information

[ Symbol ]:

GHS07, GHS08

[ Signal Word ]:
Danger

[ Hazard Statements ]:
H315-H319-H334-H335

[ Precautionary Statements ]:
P261-P305 + P351 + P338-P342 + P311

[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Faceshields;Gloves

[ Hazard Codes ]:
Xi:Irritant

[ Risk Phrases ]:
R36/37/38;R42

[ Safety Phrases ]:
S26-S36

[ RIDADR ]:
UN3261

[ WGK Germany ]:
3

[ Packaging Group ]:
III

[ Hazard Class ]:
8

[ HS Code ]:
2916399090

Synthetic Route

Precursor & DownStream

Customs

[ HS Code ]: 2916399090

[ Summary ]:
2916399090 other aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0%

Articles

J. Chem. Soc. Chem. Commun. , 399, (1993)

Effect of conformational mobility and hydrogen-bonding interactions on the selectivity of some guanidinoaryl-substituted mechanism-based inhibitors of trypsin-like serine proteases.

J. Med. Chem. 35 , 4297, (1992)

Previously, we have reported that some guanidino-substituted alpha- and beta-aryl enol lactones I and II behaved as selective, mechanism-based inhibitors of some trypsin-like proteases (Rai, R.; Katze...

Synthesis and anti-inflammatory activity of the major metabolites of imrecoxib.

Bioorg. Med. Chem. Lett. 19(8) , 2270-2, (2009)

We have developed a novel and moderately selective COX-2 inhibitor, imrecoxib, as a new anti-inflammatory drug. We describe herein the preparation of the major metabolites M2 and M4 of imrecoxib, as w...


More Articles


Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.